6-Bromo-3H-isobenzofuran-1-one - CAS 19477-73-7
Catalog: |
BB062012 |
Product Name: |
6-Bromo-3H-isobenzofuran-1-one |
CAS: |
19477-73-7 |
Synonyms: |
6-bromo-3H-isobenzofuran-1-one; 6-bromoisobenzofuran-1(3h)-one; 6-Bromophthalide; 6-bromo-3H-2-benzofuran-1-one; 6-Bromo-2-benzofuran-1(3H)-one; 1(3H)-Isobenzofuranone, 6-bromo-; 6-bromo-3 h-isobenzofuran-1-one; 6-bromo-1,3-dihydro-2-benzofuran-1-one |
IUPAC Name: | 6-bromo-3H-2-benzofuran-1-one |
Description: | 6-Bromo-3H-isobenzofuran-1-one |
Molecular Weight: | 213.03 |
Molecular Formula: | C8H5BrO2 |
Canonical SMILES: | C1C2=C(C=C(C=C2)Br)C(=O)O1 |
InChI: | InChI=1S/C8H5BrO2/c9-6-2-1-5-4-11-8(10)7(5)3-6/h1-3H,4H2 |
InChI Key: | BELKVKMBIAENSA-UHFFFAOYSA-N |
Melting Point: | 99 - 101°C |
Solubility: | Chloroform (Slightly), Methanol (Slightly) |
Appearance: | White to Off-White Solid |
Storage: | -20°C, Hygroscopic |
GHS Hazard Statement: | H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021249522-A1 | Pyridone-containing fused ring derivative inhibitor, preparation method therefor, and use thereof | 20200612 |
WO-2021249534-A1 | Phthalazinone compound, and preparation method therefor and medical use thereof | 20200612 |
WO-2020257632-A1 | Allosteric egfr inhibitors and methods of use thereof | 20190621 |
CA-3144512-A1 | Allosteric egfr inhibitors and methods of use thereof | 20190621 |
CN-114206342-A | Allosteric EGFR inhibitors and methods of use thereof | 20190621 |
CN-111825656-A | Inhibitors of protein arginine methyltransferase 5(PRMT5), pharmaceutical products thereof, and methods thereof | 20190415 |
WO-2019179346-A1 | Benzoic acid compounds and preparation method therefore and applications thereof | 20180319 |
WO-2019173804-A1 | Inhibitors of protein arginine methyltransferase 5 (prmt5), pharmaceutical products thereof, and methods thereof | 20180309 |
CA-3090836-A1 | Inhibitors of protein arginine methyltransferase 5 (prmt5), pharmaceutical products thereof, and methods thereof | 20180309 |
KR-20200119859-A | Inhibitors of protein arginine methyltransferase 5 (PRMT 5), pharmaceutical products thereof, and methods thereof | 20180309 |
PMID | Publication Date | Title | Journal |
21500832 | 20110609 | Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs | Journal of medicinal chemistry |
Complexity: | 181 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 211.94729 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 211.94729 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 26.3Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS